Clinical Effect of Apatinib Mesylate Tablets Combined with Paclitaxel Concurrent Radiotherapy and Chemotherapy in the First-Line Treatment of Locally Advanced Nasopharyngeal Carcinoma
Objective. To explore the clinical efficacy and safety of apatinib combined with paclitaxel in the first-line treatment of locally advanced nasopharyngeal carcinoma. Methods. From March 2016 to June 2018, 114 patients with locally advanced nasopharyngeal carcinoma who received first-line treatment i...
Saved in:
Main Authors: | Dechao Zhan, Zihong Chen, Donghong Yang, Jiyu Wen, Wanwan Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Emergency Medicine International |
Online Access: | http://dx.doi.org/10.1155/2022/6293816 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Retracted: Clinical Effect of Apatinib Mesylate Tablets Combined with Paclitaxel Concurrent Radiotherapy and Chemotherapy in the First-Line Treatment of Locally Advanced Nasopharyngeal Carcinoma
by: Emergency Medicine International
Published: (2024-01-01) -
Tension Pneumocephalus Related to Radiotherapy for Nasopharyngeal Carcinoma
by: Esther Jimenez-Jimenez, et al.
Published: (2014-01-01) -
Combination Use of Tegafur and Apatinib as First-Line Therapy in Treatment of Advanced Gastric Cancer: A Single-Blinded Randomized Study
by: Chaofeng Li, et al.
Published: (2020-01-01) -
Chemoimmunotherapy as induction treatment in concurrent chemoradiotherapy for patients with nasopharyngeal carcinoma stage IVa
by: Kun-Peng Wu, et al.
Published: (2025-12-01) -
Study of PEG-rhG-CSF for the prevention of neutropenia in concurrent chemoradiotherapy for nasopharyngeal carcinoma
by: Lu Yang, et al.
Published: (2025-01-01)